Hiromasa Ogawa Selected Research

Hiromasa Ogawa Research Topics

Disease

6	Chronic Obstructive Pulmonary Disease (COPD) 05/2024 - 01/2004
4	Obstructive Sleep Apnea 01/2011 - 11/2003
3	Pulmonary Alveolar Proteinosis 01/2018 - 04/2006
3	Apnea 01/2016 - 06/2005
2	Malnutrition (Nutritional Deficiencies) 05/2024 - 06/2003
2	Sleep Apnea Syndromes (Sleep Apnea) 01/2022 - 01/2022
2	Inflammation (Inflammations) 01/2018 - 01/2005
2	Heart Failure 01/2016 - 01/2016
2	Airway Obstruction (Choking) 01/2011 - 01/2005
2	Disease Progression 04/2006 - 04/2004
2	Hypoxia (Hypoxemia) 01/2006 - 07/2004
2	Dyspnea (Shortness of Breath) 06/2003 - 04/2002
1	Sarcopenia 05/2024
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Glaucoma 01/2020
1	Rare Diseases (Rare Disease) 08/2017
1	Central Sleep Apnea (Central Sleep Apnea Syndrome) 01/2016
1	Ventricular Tachycardia 01/2016
1	Wounds and Injuries (Trauma) 01/2015
1	Sleep Wake Disorders 01/2011
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2011
1	Lung Neoplasms (Lung Cancer) 01/2007
1	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2006
1	Hypercapnia 07/2004
1	Pulmonary Sarcoidosis 04/2004
1	Lymphadenopathy 04/2004
1	Anterior Uveitis 04/2004
1	Sarcoidosis (Schaumann Disease) 04/2004
1	Lung Diseases (Lung Disease) 01/2004
1	Asthma (Bronchial Asthma) 01/2004
1	Pulmonary Emphysema 06/2003
1	Cachexia 06/2003
1	Emphysema 06/2003

Drug/Important Bio-Agent (IBA)

7	Oxygen (Dioxygen)IBA 01/2016 - 06/2003
2	Proteins (Proteins, Gene)FDA Link 08/2017 - 01/2004
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2017 - 04/2006
2	Biomarkers (Surrogate Marker)IBA 01/2011 - 04/2006
2	Interleukin-1beta (Interleukin 1 beta)IBA 01/2007 - 01/2005
2	CytokinesIBA 01/2007 - 01/2005
2	heme oxygenase-2IBA 01/2006 - 07/2004
1	Indicators and Reagents (Reagents)IBA 05/2024
1	Smad7 ProteinIBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	Mitochondrial Uncoupling ProteinsIBA 01/2022
1	Procaterol (Pro-Air)IBA 03/2019
1	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 03/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	AutoantibodiesIBA 08/2017
1	Acetaminophen (Paracetamol)FDA LinkGeneric 08/2017
1	Surface-Active Agents (Surfactants)IBA 08/2017
1	Carbon DioxideIBA 01/2016
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2016
1	CollagenIBA 01/2015
1	Formoterol Fumarate (Oxis)FDA Link 01/2008
1	AntioxidantsIBA 01/2007
1	CatalaseIBA 01/2007
1	EnzymesIBA 01/2007
1	Epoxide HydrolasesIBA 01/2007
1	Peptide Hydrolases (Proteases)FDA Link 01/2007
1	Messenger RNA (mRNA)IBA 01/2007
1	TransferasesIBA 01/2007
1	XenobioticsIBA 01/2007
1	Interleukin-8 (Interleukin 8)IBA 01/2007
1	Oxidants (Oxidizing Agents)IBA 01/2007
1	ChemokinesIBA 01/2007
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2007
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2007
1	CC ChemokinesIBA 01/2007
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 01/2006
1	Xanthine OxidaseIBA 01/2005
1	Interferon-gamma (Interferon, gamma)IBA 01/2005
1	Superoxides (Superoxide)IBA 01/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2005
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2005
1	Ophthalmic Solutions (Eye Drops)IBA 04/2004
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2004
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2004
1	Betamethasone (Celestone)FDA Link 04/2004
1	3-nitrotyrosineIBA 01/2004
1	Reactive Nitrogen SpeciesIBA 01/2004
1	Tyrosine (L-Tyrosine)FDA Link 01/2004
1	Doxapram (Doxapram Hydrochloride)FDA LinkGeneric 04/2002

Therapy/Procedure

5	Therapeutics 01/2022 - 04/2004
3	Continuous Positive Airway Pressure 01/2022 - 11/2003
1	Respiratory Therapy (Therapy, Respiratory) 01/2016
1	Pressure Transducers (Pressure Transducer) 06/2005
1	Tonsillectomy 06/2004
1	Aftercare (After-Treatment) 06/2004
1	Pneumonectomy (Lung Volume Reduction) 06/2003